Gene Name |
acetylcholinesterase (Yt blood group) |
laminin, alpha 1 |
Image |
|
No pdb structure |
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Choline
- Tacrine
- Gallamine Triethiodide
- Pyridostigmine
- Galantamine
- Isoflurophate
- Pralidoxime
- Minaprine
- Donepezil
- Demecarium
- Physostigmine
- Rivastigmine
- Edrophonium
- Ambenonium
- Tubocurarine
- Decamethonium
- Ephedrine
- Neostigmine
- Monoisopropylphosphorylserine
- Huperaine A
- Propidium
- 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium
- 3,6,9,12,15-Pentaoxaheptadecane
- 1-Deoxy-1-Thio-Heptaethylene Glycol
- (4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium
- Methylphosphonic Acid Ester Group
- Methylphosphinic Acid
- 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium
- Acetylcholine
- beta-L-fucose
- M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene
- 2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose
- 2-(N-Morpholino)-Ethanesulfonic Acid
- MF268
- 3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine
- 3-[(1s)-1-(Dimethylamino)Ethyl]Phenol
- (R)-tacrine(10)-hupyridone
- (S)-tacrine(10)-hupyridone
- TACRINE(8)-4-AMINOQUINOLINE
- (9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM
- 1-(2-nitrophenyl)-2,2,2-trifluoroethyl]-arsenocholine
- 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE
- 1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL
- (1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE
- 1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE
- 3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM
- 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE
- 2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM
|
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
9 interactors:
APP
COL1A1
COL4A1
COLQ
EIF2D
HAND1
LAMA1
LAMB1
PRIMA1
|
19 interactors:
ACHE
APCS
APP
C3
COL7A1
DAG1
FBLN2
HSPG2
ITGA1
ITGA2
ITGB1
MEP1A
NID1
NT5E
PLAT
PLG
SAA1
SAA2
TMPRSS6
|
Entrez ID |
43 |
284217 |
HPRD ID |
00010 |
01033 |
Ensembl ID |
ENSG00000087085
|
ENSG00000101680
|
Uniprot IDs |
P22303
|
P25391
|
PDB IDs |
1B41
1F8U
1PUV
1PUW
1VZJ
2CLJ
2X8B
3LII
4BDT
4EY4
4EY5
4EY6
4EY7
4EY8
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
acetylcholinesterase
amphetamine
atropine
bring
ceb
diazepam
drl
irreversible
ld50
mecamylamine
methylatropine
modafinil
muscarinic
opc
organophosphorus
oximes
physostigmine
pralidoxime
psychotropic
pyridostigmine
pyrimidoxime
reinforcement
responding
sarin
schedule
scopolamine
soman
subtoxic
wakening
|
annexin2
col1a1
committed
desensitized
ecm
fbln1
fbn2
fibrillin
fibullin
fn1
has1
hsc
hyaluronan
ifi
ifi44l
ifit1
ifnbeta
isgf3
laminin
mineralization
modifies
niche
opn
osteoblast
osteoblasts
osteoimmunology
osteopontin
pinpoints
timing
|
Tagcloud (Difference) ? |
acetylcholinesterase
amphetamine
atropine
bring
ceb
diazepam
drl
irreversible
ld50
mecamylamine
methylatropine
modafinil
muscarinic
opc
organophosphorus
oximes
physostigmine
pralidoxime
psychotropic
pyridostigmine
pyrimidoxime
reinforcement
responding
sarin
schedule
scopolamine
soman
subtoxic
wakening
|
annexin2
col1a1
committed
desensitized
ecm
fbln1
fbn2
fibrillin
fibullin
fn1
has1
hsc
hyaluronan
ifi
ifi44l
ifit1
ifnbeta
isgf3
laminin
mineralization
modifies
niche
opn
osteoblast
osteoblasts
osteoimmunology
osteopontin
pinpoints
timing
|
Tagcloud (Intersection) ? |
|